Pyrazinamide (PZA) is a first-line antituberculosis (anti-TB) drug capable of killing nonreplicating, persistent Mycobacterium tuberculosis. However, reliable testing of the susceptibility of M. tuberculosis to PZA is challenging. Using 432 clinical M. tuberculosis isolates, we compared the performances of five methods for the determination of M. tuberculosis susceptibility to PZA: the MGIT 960 system, the molecular drug susceptibility test (mDST), the pyrazinamidase (PZase) activity assay, the resazurin microtiter assay (REMA), and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction test. The sensitivities of the MGIT 960 system, the PZase activity assay, the mDST, the REMA, and the MTT assay were 98.8%, 88.8%, 90.5%, 98.8%, and 98.2%, respectively. The sensitivities of the PZase activity assay and the mDST were lower than those of the other three methods (P < 0.05). The specificities of the MGIT 960 system, the PZase activity assay, the mDST, the REMA and the MTT assays were 99.2%, 98.9%, 90.9%, 98.5%, and 100%, respectively. The specificity of the mDST was lower than those of the other four methods (P < 0.05). In conclusion, the MGIT 960 system, the MTT assay, and the REMA are superior to the PZase activity assay and the mDST in determining the susceptibility of M. tuberculosis to PZA. The MTT assay and the REMA might serve as alternative methods for clinical laboratories without access to the MGIT 960 system. For rapid testing in well-equipped laboratories, the mDST might be the best choice, particularly for small quantities of M. tuberculosis. The PZase activity assay has no obvious advantage in the assessment of M. tuberculosis susceptibility to PZA, as it is less accurate and requires larger quantities of bacteria.
P yrazinamide (PZA) is a first-line antituberculosis (anti-TB) drug.
It is often used in combination with isoniazid, ethambutol, and rifampin for the treatment of TB (1) . PZA can shorten TB treatment time from the 9 to 12 months required prior to its introduction to the current standard treatment time of 6 months. This is often referred to as short-course chemotherapy (2) . PZA is more effective against nonreplicating, persistent Mycobacterium tuberculosis than any other conventional anti-TB drug (3) . However, reliable testing of the susceptibility of M. tuberculosis to PZA in vitro is challenging since PZA has no apparent effect on actively growing TB bacilli under normal culture conditions at neutral pH. PZA is effective against M. tuberculosis only at an acidic pH, and acidic media inhibit the growth of M. tuberculosis (4, 5) . The Bactec 460 and MGIT 960 are the only two methods recommended by the World Health Organization (WHO) for susceptibility testing of M. tuberculosis to PZA, due to the difficulty in standardizing its susceptibility to PZA on solid media (6) . Drug susceptibility testing in liquid media is costly, especially in some regions that do not have enough economic capabilities (6) . Several other drug susceptibility-testing methods have been developed, including the molecular drug susceptibility test (mDST) based on the detection of a pncA mutation, the pyrazinamidase (PZase) activity assay, and colorimetric methods based on a minimal inhibitory concentration (MIC) or redox indicator (7, 8, 9, 10, 11, 12) . In this study, we used 432 clinical M. tuberculosis isolates to compare five methods for determination of the susceptibility of M. tuberculosis to PZA: the MGIT 960 system, the mDST, the PZase activity assay, and two colorimetric methods [the resazurin microtiter assay (REMA) and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction test].
MATERIALS AND METHODS
Strains. Clinical M. tuberculosis specimen samples were randomly collected from 432 tuberculosis patients in Shanghai Pulmonary Hospital from January to December of 2011. All of the isolates were identified as M. tuberculosis using PCR based on the IS6110 sequence and a sequence based on the pncA gene (13, 14) . The M. tuberculosis type strain H37Rv (ATCC 27294) and Mycobacterium bovis type strain (ATCC 19210) were gifts from the National Tuberculosis Reference Laboratory (Beijing, China). The H37Rv strain served as a PZA-susceptible control, and M. bovis served as a PZA-resistant control. All of the strains were cultured for 3 to 4 weeks in Middlebrook 7H9 liquid medium with 10% oleic albumin dextrose catalase (OADC) supplement (Becton Dickinson, Franklin Lakes, NJ) and then used in the PZA susceptibility tests.
Testing of M. tuberculosis susceptibility to PZA using the MGIT 960 system. MGIT 960 PZA kits were purchased from Becton Dickinson. The concentration of PZA used was 100 mg/liter (6) . Prior to inoculating the PZA set tubes, 0.8 ml Bactec MGIT 960 PZA supplement was added to the growth control and PZA tubes, and 100 l PZA solution was added to the PZA tubes. Inocula were prepared in accordance with the manufacturer's instructions. Each colony was transferred into a sterile tube containing 4 ml Middlebrook 7H9 medium with 8 to 10 sterile glass beads. The suspension was vortexed for 3 min and left standing undisturbed for 20 min. The supernatant was transferred into a sterile tube and left standing undisturbed for 15 min. Finally, the supernatant was transferred into a third sterile tube. The turbidity was adjusted to a 0.5 McFarland standard and then diluted 1:5 with sterile saline. The MGIT PZA tubes with PZA were then inoculated with a 0.5-ml suspension. The growth control tube was inoculated with 0.5 ml of a 1:10 dilution of the M. tuberculosis suspension. All inoculated PZA sets were loaded into the Bactec MGIT 960 instrument. Using predefined algorithms, readings were automatically interpreted by the Epicenter data system of the MGIT 960 instru-ment, and each colony was reported as either susceptible or resistant. The unloaded PZA set report listed growth units, time to results, and susceptible, resistant, or invalid results (15, 16) .
mDST. Genomic DNA was extracted from the M. tuberculosis strains as described previously (17) . The entire pncA gene and 82 bp of an upstream putative regulatory sequence were amplified by PCR with the forward primer 5=-CGGTTTCCTTGCCCTGCGGT-3= and the reverse primer 5=-CGATGGCCTCATGCCCCACC-3=. PrimeSTAR HS DNA polymerase (TaKaRa, Dalian, China) was used in the PCR. To determine the pncA sequence, PCR products were purified and sequenced by the BGI Company (Shenzhen, China). The primers were designed using Primer-BLAST software with reference to the pncA gene sequences of M. tuberculosis (GenBank accession number NC_000962.2).. The presence of any nuclear acid substitution in the promoter region of the pncA gene or any amino acid substitution in the pncA coding region was considered indicative of PZA resistance. Otherwise, the strain was considered susceptible to PZA.
The C terminus of the rpsA gene was amplified by PCR with the forward primer 5=-GCGGTGTGGACGGTCTGGTG-3= and the reverse primer 5=-GCCCGGCTGGACCACTTCAC-3= in all of the strains that were detected as strains resistant to PZA by MGIT 960 testing without mutations in the promoters of the pncA and pncA genes or that showed positive results under the PZase activity assay (18) .
PZase activity assay. The PZase activities of the M. tuberculosis strains were assessed using a modified Wayne's procedure as described by Morlock et al. (19, 20) . Dubos broth (Difco Laboratories, Detroit, MI,) with 100 mg/liter PZA was used. Three individuals examined all of the tubes independently. The PZase activity assay was considered positive if a pink band was observed in the upper part of the test medium after incubation at 37°C for 10 days. Strains found positive under the PZase activity assay were considered PZA susceptible. PZA-resistant M. bovis served as a negative control, and M. tuberculosis H37Rv served as a positive control.
Colorimetric methods. Two colorimetric methods, the resazurin microtiter assay (REMA) and the MTT reduction test, were used for each M. tuberculosis strain simultaneously.
The REMA plate method was carried out as described by Rivoire et al. (21) . The REMA was performed in a 96-well plate. Middlebrook 7H9 medium supplemented with OADC enrichment was prepared according to the manufacturer's instructions, and the pH was adjusted to 5.9 using 1 mol/liter KH 2 PO 4 (12) . PZA was diluted to final concentrations of 12.5 to 3,200 mg/liter. One hundred microliters of each standardized bacterial inoculum, with a turbidity equivalent to that of a 1 McFarland standard, was diluted 1:20 in Middlebrook 7H9 medium, the pH was adjusted to 5.9, and then the mixture was inoculated. A PZA-free 100% growth control, containing the same number of M. tuberculosis cells as the testing well with PZA, was prepared. A PZA-free 10% growth control, containing 10% of the M. tuberculosis cells of the testing well with PZA, was also prepared. The third sterile control, containing only liquid culture medium, was prepared as well (22) . The plates were covered with lids, placed in a plastic bag, and incubated at 37°C. When white bacterial sediments were observed with the naked eye in the 10% growth control, 30 l of freshly prepared 0.01% resazurin (Sigma, St. Louis, MO) solution was added to each well, and the plates were reincubated at 37°C for 24 h. The MIC was defined as the lowest PZA concentration capable of preventing the color change from blue to pink due to resazurin reduction. M. tuberculosis strains in which the MIC was Յ100 mg/liter were considered susceptible to PZA by the REMA; otherwise, the strains were considered resistant to PZA.
The MTT assay was carried out as described by Abate and coworkers (23) . The inoculum was prepared as described above for the REMA plate method, and the same drug concentration ranges were used. Preparation of the 96-well plates was identical to that described for the REMA plate. When white bacterial sediments were observed with the naked eye in the well with the 10% growth control, 10 l of the MTT solution (5 g/liter) was added to each well, and the plate was reincubated at 37°C overnight.
When a violet precipitate (formazan) appeared, 50 l of SDS-DMF solution (a mixture of 1:1 [vol/vol] 20% sodium dodecyl sulfate and a solution of 50% N,N-dimethylformamide) was added to the wells, and the plate was reincubated at 37°C for 3 h. The MIC was defined as the lowest PZA concentration capable of preventing the color change from yellow to violet due to MTT reduction. Strains in which the MIC was Յ100 mg/liter were considered susceptible to PZA by the MTT assay; otherwise, the isolates were considered resistant to PZA.
Resolution of discrepancies. If there were any discrepancies in the results for one strain among the five methods, the five methods were then repeated an additional two times. The same results in at least two of the three tests for one method were considered the final results.
Data analysis. Data analysis was carried out using MedCalc software (MedCalc, Belgium). A comparison of the sensitivities and specificities was performed using a chi-square test.
RESULTS
Of the 432 clinical M. tuberculosis isolates, 169 were determined to be resistant to PZA and 263 susceptible to PZA by the MGIT 960 system, 149 strains were determined to be resistant to PZA and 259 strains susceptible to PZA by the PZase activity assay, 153 strains were determined to be resistant to PZA and 239 isolates susceptible to PZA by the mDST, 164 strains were determined to be resistant to PZA and 257 strains susceptible to PZA by the REMA, and 164 strains were determined to be resistant to PZA and 262 strains susceptible to PZA by the MTT assay (Table 1) . No mutation was found in any part of the 117-amino-acid C terminus of RpsA in the 20 strains found resistant to PZA by the MGIT 960 test without mutations in the promoters and structural gene of pncA or in the 8 strains resistant to PZA by MGIT 960 testing that showed positive results by the PZase activity assay.
In comparison to the results obtained with the MGIT 960 system (as a reference of 100% sensitivity), the sensitivities of the PZase activity assay, the mDST, the REMA, and the MTT assay were 88.2%, 90.5%, 97.0%, and 97.0%, respectively. The sensitivities of the REMA and the MTT assay were significantly higher than those of the mDST and the PZase activity assay ( 2 ϭ 9.719, P Ͻ 0.05, and 2 ϭ 6.144, P Ͻ 0.05, respectively). There was no significant difference when we compared the sensitivities of the REMA and the MTT assay and no significant difference when we compared the sensitivities of the mDST and the PZase activity assay (P Ͼ 0.05). The specificities of the PZase activity assay, the mDST, the REMA, and the MTT assay were 98.5%, 90.9%, 97.7%, and 99.6%, respectively. The specificities of the PZase activity assay, the REMA, and the MTT assay were significantly higher than that of the mDST ( 2 ϭ 38.155, P Ͻ 0.05). There was no significant difference among the specificities of the PZase activity assay, the REMA, and the MTT assay (P Ͼ 0.05).
Of the 432 M. tuberculosis strains, 374 strains showed the same drug susceptibility testing results with all of the five methods examined, and 58 strains showed different results ( Table 2) . Among 58 discrepant results, 39 results were the same with four testing methods, while 10 results of the PZase activity assay, 26 results of the mDST, and 3 results of the REMA were different from those from the other four methods. Among 58 discrepant results, 19 results were the same for three methods but different from those for the other two methods. When the results were the same in three methods or when more than three methods yielded reference results, there were 169 isolates that were resistant to PZA and 263 isolates that were susceptible to PZA. The sensitivities of the MGIT 960 system, the PZase activity, the mDST, the REMA, and the MTT assay were 98.8%, 88.8%, 90.5%, 98.8%, and 98.2%, respectively ( Table 3 ). The MGIT 960 system, the REMA, and the MTT assay showed higher sensitivities than those of the PZase activity assay and the mDST (P Ͻ 0.05). There were no significant differences among sensitivities of the MGIT 960 system, the REMA, and the MTT assay and no significant difference when comparing the sensitivities of the mDST and the PZase activity assay (P Ͼ 0.05). The specificities of the MGIT 960 system, the PZase activity assay, the mDST, the REMA, and the MTT assay were 99.2%, 98.9%, 90.9%, 98.5%, and 100%, respectively ( Table  3 ). The MGIT 960 system, the REMA, the MTT, and the PZase activity assay showed higher specificities than that of the mDST ( 2 ϭ 60.177, P Ͻ 0.05). There were no significant differences among the specificities of the MGIT 960 system, the REMA, the MTT, and the PZase activity assay (P Ͼ 0.05).
Several parameters related to clinical application were also analyzed. The mDST was found to be the fastest of the methods examined here, needing only 1 day. The other four methods needed about 7 to 18 days once a pure isolate was obtained in order to finish the test. While the mDST required only a very small quantity of bacteria, on the order of several CFU, the PZase activity assay required a much larger quantity of bacteria (at least 3 to 5 mg). An insufficient number of bacteria in the PZase activity assay can lead to falsely negative results. The PZase activity assay, the REMA, and the MTT test do not require any special equipment other than a constant-temperature incubator; however, the MGIT 960 system and the mDST do require special equipment, such as MGIT equipment and a DNA sequencer.
DISCUSSION
Drug-resistant TB has increased patient morbidity and mortality as well as treatment-associated costs (24) . Rapid and accurate drug susceptibility testing methods are important in the selection of appropriate TB drugs. Understanding drug resistance patterns within a given community is also of enormous epidemiological significance, since it provides indicators of the existence and prevalence of primary and acquired drug resistance, which can be useful in the evaluation of the efficacy of anti-TB treatment (25, 26) . For most anti-TB drugs, such as rifampin, isoniazid, ethambutol, and streptomycin, several WHO-recommended methods of assessing susceptibility testing are available. These include the Lowenstein-Jensen, Middlebrook 7H10, Middlebrook 7H11, Bactec 460, and MGIT 960 methods. However, only the Bactec 460 and MGIT 960 methods are recommended by the WHO for PZA, one of the most important early oral anti-TB agents (6) . The main reason for this is that many of the other methods of testing susceptibility to PZA have certain disadvantages, such as poor or slow growth and difficult standardization, that render them unsuitable for use in clinical mycobacteriology laboratories. Several other methods of testing the susceptibility of M. tuberculosis to PZA have been developed. These include the mDST based on the detection of pncA mutations, the PZase activity assay, and the colorimetric methods, which are based on MIC and redox indicators (7, 8, 9, 10, 11, 12) . A few studies on the performances of these methods have been reported (7, 8, 9, 10, 11, 12) ; however, few studies have been done on the use of these methods for testing the susceptibility of M. tuberculosis to PZA or comparing several methods synchronously using large quantities of clinically isolated M. tuberculosis strains.
Our study was a one-to-one comparison of the performances of five methods for testing the susceptibility of M. tuberculosis to PZA by using 432 clinical M. tuberculosis isolates. The MGIT 960 system was used as a reference according to guidelines from the WHO (6). The sensitivity and specificity of the MTT assay were found to be the best, followed by the REMA. The sensitivities of the mDST and the PZase activity assay were similar, and the spec- ificity of the PZase activity assay was found to be better than that of the mDST. Some studies reported the potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing the susceptibility of Mycobacterium tuberculosis to PZA (27, 28) . Another study showed that the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against PZA should be reevaluated and revised (29) . Several previous reports suggested that there were some deficiencies in the MGIT 960 system. In the current study, we used three or more methods for reference results. The performance of the MGIT 960 system showed perfect agreement with the reference results (kappa value ϭ 0.98). Although 0.9% (4/432) of the strains showed discrepant results between the MGIT 960 system and the reference results, no one result from the MGIT 960 system was absolutely different from those of the other four testing methods for one strain. The results using the MGIT 960 system from two strains were concordant with those from the mDST; one was concordant with the MTT assay, and one was concordant with the PZase activity assay. We speculated that the main reason for the discrepant results from the MGIT system was the difference in methodologies.
The REMA and the MTT test also showed the same performance as the MGIT 960 system for the susceptibility testing of PZA (kappa values ϭ 0.97 and 0.99, respectively). Although there were some discrepancies among the MGIT 960 system and the REMA and the MTT assay, the discrepancies were likely due to the difference in methodology. The MGIT 960 system records bacterial growth by oxygen consumption in liquid culture, while the REMA and the MTT test indicate bacterial growth through redox reactions. Neither of them directly reflects changes in the amount of bacteria.
The results using other methods also offered some important hints. The PZase assay and the mDST are all based on the assumption that PZA-susceptible M. tuberculosis strains produce pyrazinamidase, which hydrolyzes PZA to the antibacterial moiety pyrazinoic acid (POA) (30) . pncA is a gene encoding pyrazinamidase. Previous studies have verified that the mutation in pncA can inactivate PZase and confer resistance to PZA (31) . The current study indicated that the assumption regarding the mechanism of M. tuberculosis resistance to PZA based on pyrazinamidase did not explain all of the resistance mechanisms of M. tuberculosis to PZA.
In this study, 9.5% (16/169) of the PZA-resistant strains were determined to be positive to PZase activity testing, indicating that, for these strains, PZA resistance was not caused by the inactivation of PZase but by some other unknown cause(s). Other studies have also detected PZase activity in PZA-resistant strains (10, 32, 33) . Only 1% (3/260) of the PZA-susceptible strains was negative according to the PZase activity assay, probably due to the weak activity of PZase or to the small quantity of M. tuberculosis, which makes it difficult to observe the Wayne assay color change with the naked eye at 10 days. Recently, Zhou et al. reported a new PCR-based in vitro-synthesized pyrazinamidase method. This method might exclude false negatives from the PZase activity assay due to the small quantity of M. tuberculosis (34) ; however, this method does not solve the false susceptibility of the PZase activity assay. False susceptibility is the major limitation of the PZase activity assay and should be considered seriously in clinical settings.
The mDST is an indirect method of assessing PZA susceptibility. PZase is inferred by the assessment of changes in the sequence of pncA. If no amino acid substitution is detected in the coding In this study, amino acid substitutions in the pncA genes of PZA-susceptible strains were also detected. Most of these strains were positive for PZase activity. According to previous studies, mutations at certain amino acid sites, such as codons 8, 96, 134, and 138, at active sites, and codons 13, 49, 51, 57, and 68, coordinated to the Fe 2ϩ ion, are closely associated with M. tuberculosis resistance to PZA (35, 36) . Mutations at these sites can cause M. tuberculosis to lose PZase activity and render the strain resistant to PZA. In this study, most amino acid substitutions in PZA-susceptible strains were far from the functional sites, and almost all of the amino acid substitutions occurred in PZA-susceptible strains. For this reason, we hypothesized that these amino acid substitutions did not lead to the loss of PZase activity. The in vitro-synthesized PZase assay can evaluate the correlation between the amino acid substitutions and PZase activity. If the amino acid substitutions far from the activity sites of PZase can be confirmed to be irrelevant to M. tuberculosis resistance to PZA, then the specificity of the mDST can be improved. Additionally, Zhang and coworkers found that POA binds to RpsA, subsequently inhibiting transtranslation rather than canonical translation (18) . They found that the deletion of amino acid 438 in the C terminus of RpsA can cause resistance to PZA in a clinical M. tuberculosis isolate lacking pncA mutations. In the current study, we did not detect the deletion of amino acid 438 in the C terminus of RpsA and did not find any other mutation in the C terminus of RpsA. This suggests that the mutation rate of this site in the rpsA gene in clinical M. tuberculosis isolates is too low to be a detection target for mDST. The sensitivities of the PZase activity assay and the mDST test should be improved to further clarify what the mechanism of PZA resistance is.
The MGIT 960 system, used as a reference method by the WHO, is still a good PZA susceptibility testing method for M. tuberculosis. The MTT test and the REMA are suitable alternatives to the MGIT 960 system for laboratories that do not have access to the MGIT 960 system. The mDST does not take the place of the phenotype drug susceptibility test due to the low sensitivity and specificity, but it can satisfy the rapid test requirements and functions using smaller quantities of M. tuberculosis than some other types of high-end laboratory equipment. Although the specificity of the PZase activity assay is high, the PZase activity assay has been shown to be less accurate than the MGIT 960 system, the MTT test, and the REMA, owing to their low sensitivities. In addition, the PZase activity assay requires a larger quantity of bacteria and does not take significantly less time, so there is no obvious advantage to using the PZase activity assay for the assessment of PZA susceptibility.
